The use of konjac glucomannan hydrolysates to recover healthy microbiota in infected vaginas treated with an antifungal agent

Beneficial Microbes

Volumn 3, Issue 1, 2012, Pages 61-66

  Tester, R ^a   Al Ghazzewi, F ^a   Shen, N ^b   Chen, Z ^b   Chen, F ^b   Yang, J ^b   Zhang, D ^b   Tang, M ^a  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^b Suining Hospital of Traditional Chinese Medicine   (China)

Author keywords

Candida; Konjac glucomannan; Lactobacilli; Synbiotic; Vaginal infections

Indexed keywords

ANTIFUNGAL AGENT; KONJAC GLUCOMANNAN HYDROSYLATE; PREBIOTIC AGENT; UNCLASSIFIED DRUG; KONJAC GLUCO MANNAN; KONJAC GLUCO-MANNAN; MANNAN; NYSTATIN; PLANT EXTRACT;

ARTICLE; BACTERIAL CELL; BACTERIAL COUNT; CANDIDIASIS; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GRAM POSITIVE COCCI; HUMAN; MICROFLORA; PH; RESPONSE TIME; TREATMENT DURATION; VAGINA FLORA; VAGINITIS; ADOLESCENT; ADULT; CANDIDA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; LEUKOCYTE COUNT; METAGENOME; MICROBIOLOGY; PATHOGENICITY; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIAL; VAGINA; VAGINA CANDIDIASIS; VAGINA DISEASE; VAGINA PESSARY;

ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, VULVOVAGINAL; EPITHELIAL CELLS; FEMALE; HUMANS; LEUKOCYTE COUNT; MANNANS; METAGENOME; NYSTATIN; PESSARIES; PHYTOTHERAPY; PLANT EXTRACTS; VAGINA; VAGINAL DISEASES; YOUNG ADULT;

EID: 84862253200     PISSN: 18762883     EISSN: 18762891     Source Type: Journal    
DOI: 10.3920/BM2011.0021     Document Type: Article

References (29)

1. Al-Ghazzewi, F.H. and Tester, R.F., 2010. Effect of konjac glucomannan hydrolysates and probiotics on the growth of the skin bacterium Propionibacterium acnes in vitro. International Journal of Cosmetic Science 32: 139-142.
2. Al-Ghazzewi, F.H. and Tester, R.F., 2012. The synbiotic effects of konjac glucomannan hydrolysates (GMH) and lactobacilli on the growth of Staphylococcus aureus and Salmonella typhimurium. Nutrition and Food Science 42, in press.
3. Al-Ghazzewi, F.H., Khanna, S., Tester, R.F. and Piggott, J., 2007. The potential use of hydrolysed konjac glucomannan as a prebiotic. Journal of the Science of Food and Agriculture 87: 1758-1766.
4. Barbes, C. and Boris, S., 1999. Potential role of lactobacilli as prophylactic agents against genital pathogens. AIDS Patient Care and STDs 13: 747-751.
5. Boris, S. and Barbes, C., 2000. Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes and Infection 2: 543-546.
6. Cocolin, L., Foschino, R., Comi, G. and Fortina, M.G., 2007. Description of the bacteriocins produced by two strains of Enterococcus faecium isolated from Italian goat milk. Food Microbiology 24: 752-758.
7. Drake, S.M., Evans, B.A. and Gerken, A.A., 1980. Vaginal pH and microflora related to yeast infections and treatment. British Journal of Venereal Diseases 56: 107-110.
8. Elamir, A.A., Tester, R.F., Al-Ghazzewi, F.H., Kaal, H.Y., Ghalbon, A.A., Elmegrahai, N.A. and Piggott, J.R., 2008. Effects of konjac glucomannan hydrolysates on the gut microflora of mice. Nutrition and Food Science 38: 422-429.
9. Elmer, G.W., Surawicz, C.M. and McFarland, L.V., 1996. Biotherapeutic agents: a neglected modality for the treatment and prevention of selected intestinal and vaginal infections. Journal of the American Medical Association 275: 870-876.
10. Fernandes, C.F., Shahani, K.M. and Amer, M.A., 1987. Therapeutic role of dietary lactobacilli and lactobacillic fermented dairy products. FEMS Microbiology Letters 46: 343-356.
11. Gibson, G.R. and Roberfroid, M.B., 1995. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. Journal of Nutrition 125: 1401-1412.
12. Gibson, G.R., McCartney, A.L. and Rastall, R.A., 2005. Prebiotics and resistance to gastrointestinal infections. British Journal of Nutrition 93 Suppl. 1: S31-S34.
13. Hamilton-Miller, J.M.T., 1973. The effect of pH and of temperature on the stability and bioactivity of nystatin and amphotericin B. Journal of Pharmacy and Pharmacology 25: 401-407.
14. Hamilton-Miller, J.M.T. and Shah, S., 1994. Susceptibility patterns of vaginal lactobacilli to eleven oral antibiotics. Journal of Antimicrobial Chemotherapy 33: 1059-1060.
15. Klebanoff, S.J., Hillier, S.L., Eschenbach, D.A. and Waltersdorph, A.M., 1991. Control of the microbial flora of the vagina by H2O2- generating lactobacilli. Journal of Infectious Disease 164: 94-100.
16. Maggi, L., Mastromarino, P., Macchia, S., Brigidi, P., Pirovano, F., Matteuzzi, D. and Conte, U., 2000. Technological and biological evaluation of tablets containing different strains of lactobacilli for vaginal administration. European Journal of Pharmaceutics and Biopharmaceutics 50: 389-395.
17. Mastromarino, P., Brigidi, P., Macchia, S., Maggi, L., Pirovano, F., Trinchieri, V., Conte, U. and Matteuzzi, D., 2002. Characterisation and selection of vaginal Lactobacillus strains from the preparation of vaginal tablets. Journal of Applied Microbiology 93: 884-893.
18. Reid, G. and Bruce, A.W., 2001. Selection of Lactobacillus strains for urogenital probiotic applications. Journal of Infectious Disease 183 Suppl. 1: S77-S80.
19. Reid, G., Beuerman, D., Heinemann, C. and Bruce, A.W., 2001a. Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora. FEMS Immunology and Medical Microbiology 32: 37-41.
20. Reid, G., Bruce, A.W., Fraser, N., Heinemann, C., Owen, J. and Henning, B., 2001b. Oral probiotic can resolve urogenital infections. FEMS Immunology and Medical Microbiology 30: 49-52.
21. Reid, G., Charbonneau, D., Erb, J., Kochanowski, B., Beuerman, D., Poehner, R. and Bruce, A.W., 2003. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomised, placebo-controlled trial in 64 healthy women. FEMS Immunology and Medical Microbiology 35: 131-134.
22. Sarkisov, S.E., Krymshokalova, Z.S., Kafarskaia, L.I. and Korshunov, V.M., 2000. The use of the biotherapeutic agent Zhlemik for correcting the microflora in bacterial vaginosis. Journal of Microbiology, Epidemiology and Immunobiology 1: 88-90.
23. Sobel, J.D., 1992. Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clinical Infectious Disease 14 Suppl. 1: S148-S153.
24. Sobel, J.D. and Chaim, W., 1996. Vaginal microbiology of women with acute recurrent vulvovaginal candidiasis. Journal of Clinical Microbiology 24: 2497-2499.
25. Strus, M., Kucharska, A., Kukla, G., Brzychczy-Wloch, M. K. and Heczko, P.B., 2005. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida. Infectious Diseases in Obstetrics and Gynecology 13: 69-75.
26. Sutherland, A., Tester, R., Al-Ghazzewi, F., McCulloch, E. and Connolly, M., 2008, Glucomannan hydrolysate (GMH) inhibition of Candida albicans growth in the presence of Lactobacillus and Lactococcus species. Microbial Ecology in Health and Disease 20: 127-134.
27. Tester, R. and Al-Ghazzewi, F., 2011. A preliminary study of the synbiotic effects of konjac glucomannan hydrolysates (GMH) and lactobacilli on the growth of the oral bacterium Streptococcus mutans. Nutrition and Food Science 41: 234-237.
28. Vermerie, N., Malbrunot, C., Azar, M. and Arnaud, P., 1997. Stability of nystatin in mouthrinses; effect of pH, temperature, concentration and colloidal silver addition, studied using an in vitro antifungal activity. Pharmacy World and Science 19: 197-201.
29. Wilson, M., 2005. The reproductive system and its indigenous microbiota. In: Wilson, M. (ed.) Microbial inhabitants of humans: their ecology and role in health and disease. Cambridge University Press, New York, NY, USA, pp. 206-248.